跳至主要内容
临床试验/NCT07595718
NCT07595718招募中不适用

AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases

Jae Yong Jeon, MD1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2026年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Number of Participants With Incident Target Disease or Condition Identified Up to 10 Years After the Index Date

研究概览

简要总结

This study aims to develop and validate an artificial intelligence (AI)-based predictive model to estimate the risk of incident onset of five major diseases or conditions: cardiovascular disease, type 2 diabetes mellitus, breast cancer, low back pain, and osteoarthritis, in adults aged 30 to 60 years.

For each participant, an index date will be defined as the date of a prior health screening or another protocol-defined baseline clinical date. Incident disease status for each target disease or condition will be ascertained by retrospective review of electronic medical records for up to 10 years after the index date.

The study integrates retrospective clinical, health screening, laboratory, imaging, and electronic medical record data with prospectively collected biospecimen, proteomic, genomic, questionnaire, lifestyle, and digital health data. Prospective study procedures will be completed over approximately 1 week, with up to 2 additional weeks if needed.

By combining multimodal data, this study seeks to improve disease risk prediction and to identify clinical and biological factors associated with disease onset, ultimately supporting personalized risk stratification and preventive healthcare strategies.

详细描述

This observational study aims to develop and validate an artificial intelligence (AI)-based predictive model for assessing the risk of incident onset of five major diseases or conditions: cardiovascular disease, type 2 diabetes mellitus, breast cancer, low back pain, and osteoarthritis, in adults aged 30 to 60 years.

The study uses a hybrid retrospective and prospective data collection design. Retrospective clinical, health screening, laboratory, imaging, and electronic medical record data will be combined with prospectively collected biospecimen, proteomic, genomic, questionnaire, lifestyle, and digital health data.

For disease-onset analyses, an index date will be defined for each participant as the date of a prior health screening or another protocol-defined baseline clinical date. For each target disease or condition, participants without that target disease or condition at the index date will be classified as incident cases if a new diagnosis is identified in electronic medical records up to 10 years after the index date. Participants without a diagnosis of that target disease or condition through the available observation period will be classified as persistent controls. Disease occurrence will be ascertained through retrospective electronic medical record review rather than through new prospective long-term follow-up.

A total of approximately 1,000 participants will be enrolled. The disease group will include approximately 880 adults aged 30 to 60 years with a confirmed diagnosis of one or more of the five target diseases or conditions. The healthy control group will include approximately 120 adults aged 30 to 60 years without a prior diagnosis of any of the five target diseases or conditions.

Retrospective data collection will include medical records, health screening results, laboratory results, and imaging-related data. Prospective data collection will include blood samples for proteomic and genomic analyses, questionnaires, lifestyle and behavioral data, and digital health assessments. App-based questionnaires and digital assessments will be performed at home over approximately 7 days. If app-based sleep assessment or other digital assessments are not completed within this period, up to 2 additional weeks may be provided.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 30 to 60 years.
  • Disease group: Participants with a confirmed diagnosis of at least one of the following conditions: type 2 diabetes mellitus, breast cancer, cardiovascular disease, osteoarthritis, or low back pain.
  • Healthy control group: Participants with no prior diagnosis of type 2 diabetes mellitus, breast cancer, cardiovascular disease, osteoarthritis, or low back pain.
  • No history or current diagnosis of major medical conditions that may affect study outcomes, including but not limited to chronic kidney disease or liver cirrhosis.
  • Ability to understand the study procedures and provision of written informed consent prior to participation.

排除标准

  • Participants with incomplete or insufficient clinical or health screening data.
  • Participants considered inappropriate for study participation by the investigator.

研究组 & 干预措施

Disease Group

Adults aged 30 to 60 years with one or more of the five major diseases.

Five major diseases are Cardiovascular Diseases, Diabetes Mellitus, Type 2, Breast Neoplasms, Low Back Pain and Osteoarthritis.

Healthy Control Group

Adults aged 30 to 60 years without five major diseases.

结局指标

主要结局

Number of Participants With Incident Target Disease or Condition Identified Up to 10 Years After the Index Date

时间窗: Up to 10 years after the index date

Incident target disease or condition will be assessed for five prespecified target diseases or conditions: cardiovascular disease, type 2 diabetes mellitus, breast cancer, low back pain, and osteoarthritis. For each target disease or condition, incident occurrence will be defined as a new diagnosis recorded in electronic medical records after the index date among participants without that target disease or condition at the index date. Results will be summarized separately for each target disease or condition as the number and percentage of participants with incident disease or condition.

次要结局

  • Discriminative performance of the artificial intelligence model in distinguishing between disease and control groups using baseline data from health screenings and clinical records (AUROC, PR-AUC)(Through study completion, approximately 9 months)
  • Diagnostic Performance of the Artificial Intelligence Model for Predicting Incident Target Diseases or Conditions(Through study completion, approximately 9 months)
  • Brier Score of the Artificial Intelligence Model for Predicting Incident Target Diseases or Conditions(Through study completion, approximately 9 months)
  • Calibration Slope of the Artificial Intelligence Model for Predicting Incident Target Diseases or Conditions(Through study completion, approximately 9 months)
  • Calibration Intercept of the Artificial Intelligence Model for Predicting Incident Target Diseases or Conditions(Through study completion, approximately 9 months)

研究者

发起方
Jae Yong Jeon, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jae Yong Jeon, MD

Professor

Asan Medical Center

研究点 (1)

Loading locations...

相似试验